BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 18039422)

  • 1. Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor.
    Carethers JM
    Therap Adv Gastroenterol; 2008 Jul; 1(1):33-42. PubMed ID: 21180512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging tyrosine kinase inhibitors for the treatment of metastatic colorectal cancer.
    Matos I; Elez E; Capdevila J; Tabernero J
    Expert Opin Emerg Drugs; 2016 Sep; 21(3):267-82. PubMed ID: 27578253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Angiogenesis in Colorectal Cancer: Tyrosine Kinase Inhibitors.
    Kircher SM; Nimeiri HS; Benson AB
    Cancer J; 2016; 22(3):182-9. PubMed ID: 27341596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor tyrosine kinases expressed in metastatic colon cancer.
    Craven RJ; Xu LH; Weiner TM; Fridell YW; Dent GA; Srivastava S; Varnum B; Liu ET; Cance WG
    Int J Cancer; 1995 Mar; 60(6):791-7. PubMed ID: 7896447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study.
    Price TJ; Peeters M; Kim TW; Li J; Cascinu S; Ruff P; Suresh AS; Thomas A; Tjulandin S; Zhang K; Murugappan S; Sidhu R
    Lancet Oncol; 2014 May; 15(6):569-79. PubMed ID: 24739896
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Jin Y; Chen W; Yang H; Yan Z; Lai Z; Feng J; Peng J; Lin J
    Exp Ther Med; 2017 Dec; 14(6):5527-5534. PubMed ID: 29285087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Therapies in Elderly Patients with Metastatic Colorectal Cancer: A Review of the Evidence.
    Tapia Rico G; Townsend AR; Broadbridge V; Price TJ
    Drugs Aging; 2017 Mar; 34(3):173-189. PubMed ID: 28197947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation status.
    Gaur S; Chen L; Ann V; Lin WC; Wang Y; Chang VH; Hsu NY; Shia HS; Yen Y
    Mol Cancer; 2014 Feb; 13():21. PubMed ID: 24495750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours.
    Boven E; Massard C; Armand JP; Tillier C; Hartog V; Brega NM; Countouriotis AM; Ruiz-Garcia A; Soria JC
    Br J Cancer; 2010 Sep; 103(7):993-1000. PubMed ID: 20717111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR(S) inhibitors in the treatment of gastro-intestinal cancers: what's new?
    Kanwar SS; Nautiyal J; Majumdar AP
    Curr Drug Targets; 2010 Jun; 11(6):682-98. PubMed ID: 20298154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the pre-clinical immunogenicity of a new VEGF receptor Fc-fusion protein FP3 with ELISA and BIACORE.
    Wang H; Shi J; Wang Q; Li H; Cai K; Hou X; Li T; Zhong Q; Yu D
    Cancer Immunol Immunother; 2010 Feb; 59(2):239-46. PubMed ID: 19633845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in chemotherapy against advanced or metastatic colorectal cancer.
    Omura K
    Digestion; 2008; 77 Suppl 1():13-22. PubMed ID: 18204257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the treatment of metastatic colorectal cancer.
    Goldberg RM
    Oncologist; 2005; 10 Suppl 3():40-8. PubMed ID: 16368870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New systemic frontline treatment for metastatic colorectal carcinoma.
    Braun AH; Achterrath W; Wilke H; Vanhoefer U; Harstrick A; Preusser P
    Cancer; 2004 Apr; 100(8):1558-77. PubMed ID: 15073842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted therapy in colorectal cancer.
    Rajpal S; Venook AP
    Clin Adv Hematol Oncol; 2006 Feb; 4(2):124-32. PubMed ID: 16728921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of tyrosine kinase inhibitors in the treatment of advanced colorectal cancer.
    Grávalos C; Cassinello J; Fernández-Rañada I; Holgado E
    Clin Colorectal Cancer; 2007 Nov; 6(10):691-9. PubMed ID: 18039422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy of metastatic colorectal cancer.
    Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.